Risk-reducing salpingo-oophorectomy (RRSO) can substantially reduce ovarian cancer incidence in women carrying pathogenic BRCA1 or BRCA2 variants, which cause hereditary breast and ovarian cancer syndrome. Here, BRCA2 is linked to ovarian carcinoma.